Trials / Terminated
TerminatedNCT02081053
Evaluating Clinical Outcomes of Targeted Radiofrequency Ablation and Kyphoplasty (Also Known as Vertebral Augmentation) to Treat Painful Metastatic Vertebral Body Tumors
A Prospective, Multicenter Clinical Study to Evaluate the Clinical Outcomes of Targeted Radiofrequency Ablation and Vertebral Augmentation to Treat Painful Metastatic Vertebral Body Tumor(s)
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- DFINE Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the clinical outcomes of minimally invasive targeted radiofrequency tumor ablation (t-RFA) and kyphoplasty (also known as vertebral augmentation) in painful metastatic lesions in the spine.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | STAR™ Tumor Ablation System and StabiliT® Vertebral Augmentation System | Radiofrequency targeted radiofrequency ablation (t-RFA) and targeted vertebral augmentation (RF-TVA) |
Timeline
- Start date
- 2014-01-01
- Primary completion
- 2016-11-01
- Completion
- 2016-11-01
- First posted
- 2014-03-07
- Last updated
- 2017-01-20
Locations
8 sites across 3 countries: France, Germany, Italy
Source: ClinicalTrials.gov record NCT02081053. Inclusion in this directory is not an endorsement.